vs
Side-by-side financial comparison of ABEONA THERAPEUTICS INC. (ABEO) and Sanofi (SNY). Click either name above to swap in a different company.
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel gene and cell therapies for life-threatening rare genetic diseases. Its pipeline addresses unmet medical needs, serving patient populations across North America and European markets with limited treatment alternatives.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of th...
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $0 | — | ||
| Q2 25 | $400.0K | — |
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $108.8M | — |
| Q3 25 | — | — | ||
| Q2 25 | -5698.0% | — |
| Q3 25 | — | — | ||
| Q2 25 | 27208.3% | — |
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $1.71 | — |
